#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Medicinal Sesquiterpenes
2-1	4-13	Medicinal	substance[2]	new[2]	coref	10-6[66_2]
2-2	14-28	Sesquiterpenes	substance[2]	new[2]	_	_

#Text=Sesquiterpene biosynthesis normally begins in the cytosol via the C15 prenyl diphosphate FDP , which itself is derived from mevalonic acid and the MVA pathway .
3-1	29-42	Sesquiterpene	substance[3]	new[3]	_	_
3-2	43-55	biosynthesis	substance[3]	new[3]	_	_
3-3	56-64	normally	_	_	_	_
3-4	65-71	begins	_	_	_	_
3-5	72-74	in	_	_	_	_
3-6	75-78	the	place[4]	new[4]	_	_
3-7	79-86	cytosol	place[4]	new[4]	_	_
3-8	87-90	via	place[4]	new[4]	_	_
3-9	91-94	the	place[4]|abstract[8]	new[4]|new[8]	ana	3-16[0_8]
3-10	95-98	C15	place[4]|time|abstract[8]	new[4]|new|new[8]	_	_
3-11	99-105	prenyl	place[4]|abstract|abstract[8]	new[4]|new|new[8]	_	_
3-12	106-117	diphosphate	place[4]|person|abstract[8]	new[4]|new|new[8]	_	_
3-13	118-121	FDP	place[4]|abstract[8]	new[4]|new[8]	_	_
3-14	122-123	,	_	_	_	_
3-15	124-129	which	_	_	_	_
3-16	130-136	itself	abstract	giv	coref	4-5
3-17	137-139	is	_	_	_	_
3-18	140-147	derived	_	_	_	_
3-19	148-152	from	_	_	_	_
3-20	153-162	mevalonic	abstract|substance[11]	new|new[11]	_	_
3-21	163-167	acid	substance[11]	new[11]	_	_
3-22	168-171	and	_	_	_	_
3-23	172-175	the	abstract[13]	new[13]	_	_
3-24	176-179	MVA	abstract|abstract[13]	new|new[13]	_	_
3-25	180-187	pathway	abstract[13]	new[13]	_	_
3-26	188-189	.	_	_	_	_

#Text=Sesquiterpene synthases act on FDP to yield hundreds of sesquiterpene hydrocarbons and alcohols based on dozens of carbon skeletons .
4-1	190-203	Sesquiterpene	substance[14]	new[14]	_	_
4-2	204-213	synthases	substance[14]	new[14]	_	_
4-3	214-217	act	_	_	_	_
4-4	218-220	on	_	_	_	_
4-5	221-224	FDP	abstract	giv	coref	26-8
4-6	225-227	to	_	_	_	_
4-7	228-233	yield	_	_	_	_
4-8	234-242	hundreds	substance[16]	new[16]	coref	6-13[41_16]
4-9	243-245	of	substance[16]	new[16]	_	_
4-10	246-259	sesquiterpene	substance[16]	new[16]	_	_
4-11	260-272	hydrocarbons	substance[16]	new[16]	_	_
4-12	273-276	and	_	_	_	_
4-13	277-285	alcohols	substance	new	_	_
4-14	286-291	based	_	_	_	_
4-15	292-294	on	_	_	_	_
4-16	295-301	dozens	abstract[19]	new[19]	ana	5-1[0_19]
4-17	302-304	of	abstract[19]	new[19]	_	_
4-18	305-311	carbon	substance|abstract[19]	new|new[19]	coref	21-15
4-19	312-321	skeletons	abstract[19]	new[19]	_	_
4-20	322-323	.	_	_	_	_

#Text=They are frequently responsible for familiar scents and flavors , for instance ginger ( gingerol ) , clove , cannabis , rosemary ( β-caryophyllene ) , patchouli ( patchoulol ) , sandalwood ( α-santalene ) , and rain ( geosmin , a bacterial sesquiterpene ) .
5-1	324-328	They	abstract	giv	_	_
5-2	329-332	are	_	_	_	_
5-3	333-343	frequently	_	_	_	_
5-4	344-355	responsible	_	_	_	_
5-5	356-359	for	_	_	_	_
5-6	360-368	familiar	abstract[21]	new[21]	_	_
5-7	369-375	scents	abstract[21]	new[21]	_	_
5-8	376-379	and	_	_	_	_
5-9	380-387	flavors	abstract[22]	new[22]	_	_
5-10	388-389	,	abstract[22]	new[22]	_	_
5-11	390-393	for	abstract[22]	new[22]	_	_
5-12	394-402	instance	abstract[22]|plant[23]	new[22]|new[23]	appos	5-15[0_23]
5-13	403-409	ginger	abstract[22]|plant[23]	new[22]|new[23]	_	_
5-14	410-411	(	_	_	_	_
5-15	412-420	gingerol	plant	giv	_	_
5-16	421-422	)	_	_	_	_
5-17	423-424	,	_	_	_	_
5-18	425-430	clove	plant	new	_	_
5-19	431-432	,	_	_	_	_
5-20	433-441	cannabis	plant	new	_	_
5-21	442-443	,	_	_	_	_
5-22	444-452	rosemary	person	new	_	_
5-23	453-454	(	_	_	_	_
5-24	455-470	β-caryophyllene	substance	new	_	_
5-25	471-472	)	_	_	_	_
5-26	473-474	,	_	_	_	_
5-27	475-484	patchouli	substance	new	_	_
5-28	485-486	(	_	_	_	_
5-29	487-497	patchoulol	object	new	_	_
5-30	498-499	)	_	_	_	_
5-31	500-501	,	_	_	_	_
5-32	502-512	sandalwood	substance	new	appos	5-34
5-33	513-514	(	_	_	_	_
5-34	515-526	α-santalene	substance	giv	_	_
5-35	527-528	)	_	_	_	_
5-36	529-530	,	_	_	_	_
5-37	531-534	and	_	_	_	_
5-38	535-539	rain	substance	new	_	_
5-39	540-541	(	_	_	_	_
5-40	542-549	geosmin	substance|substance[35]	new|new[35]	ana|ana	6-1[0_35]|6-1[0_35]
5-41	550-551	,	substance[35]	new[35]	_	_
5-42	552-553	a	substance[35]|substance[37]	new[35]|new[37]	_	_
5-43	554-563	bacterial	substance[35]|substance|substance[37]	new[35]|new|new[37]	_	_
5-44	564-577	sesquiterpene	substance[35]|substance[37]	new[35]|new[37]	_	_
5-45	578-579	)	_	_	_	_
5-46	580-581	.	_	_	_	_

#Text=They are the heaviest of the volatile terpenes under standard conditions ( diterpene hydrocarbons ordinarily require heating to form gases ) .
6-1	582-586	They	substance	giv	_	_
6-2	587-590	are	_	_	_	_
6-3	591-594	the	_	_	_	_
6-4	595-603	heaviest	_	_	_	_
6-5	604-606	of	_	_	_	_
6-6	607-610	the	substance[39]	new[39]	_	_
6-7	611-619	volatile	substance[39]	new[39]	_	_
6-8	620-628	terpenes	substance[39]	new[39]	_	_
6-9	629-634	under	substance[39]	new[39]	_	_
6-10	635-643	standard	substance[39]|abstract[40]	new[39]|new[40]	_	_
6-11	644-654	conditions	substance[39]|abstract[40]	new[39]|new[40]	_	_
6-12	655-656	(	_	_	_	_
6-13	657-666	diterpene	substance[41]	giv[41]	_	_
6-14	667-679	hydrocarbons	substance[41]	giv[41]	_	_
6-15	680-690	ordinarily	_	_	_	_
6-16	691-698	require	_	_	_	_
6-17	699-706	heating	_	_	_	_
6-18	707-709	to	_	_	_	_
6-19	710-714	form	event	new	none|none	6-19[0_201]|21-14
6-20	715-720	gases	substance	new	_	_
6-21	721-722	)	_	_	_	_
6-22	723-724	.	_	_	_	_

#Text=Plant families known to be principal producers of sesquiterpene volatiles include the Lamiaceae , Geraniaceae , Rutaceae , Myrtaceae , Cannabaceae , and Gingeraceae .
7-1	725-730	Plant	person|abstract[44]	new|new[44]	_	_
7-2	731-739	families	abstract[44]	new[44]	_	_
7-3	740-745	known	_	_	_	_
7-4	746-748	to	_	_	_	_
7-5	749-751	be	_	_	_	_
7-6	752-761	principal	person[45]	new[45]	_	_
7-7	762-771	producers	person[45]	new[45]	_	_
7-8	772-774	of	person[45]	new[45]	_	_
7-9	775-788	sesquiterpene	person[45]|substance[46]	new[45]|new[46]	_	_
7-10	789-798	volatiles	person[45]|substance[46]	new[45]|new[46]	_	_
7-11	799-806	include	_	_	_	_
7-12	807-810	the	plant[47]	new[47]	_	_
7-13	811-820	Lamiaceae	plant[47]	new[47]	_	_
7-14	821-822	,	_	_	_	_
7-15	823-834	Geraniaceae	animal	new	_	_
7-16	835-836	,	_	_	_	_
7-17	837-845	Rutaceae	animal	new	_	_
7-18	846-847	,	_	_	_	_
7-19	848-857	Myrtaceae	animal	new	_	_
7-20	858-859	,	_	_	_	_
7-21	860-871	Cannabaceae	plant	new	_	_
7-22	872-873	,	_	_	_	_
7-23	874-877	and	_	_	_	_
7-24	878-889	Gingeraceae	plant	new	_	_
7-25	890-891	.	_	_	_	_

#Text=The use of these essential oils in traditional herbal medicine such as aromatherapy and Ayurvedic medicine is well documented .
8-1	892-895	The	abstract[53]	new[53]	coref	9-6[60_53]
8-2	896-899	use	abstract[53]	new[53]	_	_
8-3	900-902	of	abstract[53]	new[53]	_	_
8-4	903-908	these	abstract[53]|substance[54]	new[53]|new[54]	ana	9-6[0_54]
8-5	909-918	essential	abstract[53]|substance[54]	new[53]|new[54]	_	_
8-6	919-923	oils	abstract[53]|substance[54]	new[53]|new[54]	_	_
8-7	924-926	in	abstract[53]|substance[54]	new[53]|new[54]	_	_
8-8	927-938	traditional	abstract[53]|substance[54]|abstract[55]	new[53]|new[54]|new[55]	_	_
8-9	939-945	herbal	abstract[53]|substance[54]|abstract[55]	new[53]|new[54]|new[55]	_	_
8-10	946-954	medicine	abstract[53]|substance[54]|abstract[55]	new[53]|new[54]|new[55]	_	_
8-11	955-959	such	abstract[53]|substance[54]|abstract[55]	new[53]|new[54]|new[55]	_	_
8-12	960-962	as	abstract[53]|substance[54]|abstract[55]	new[53]|new[54]|new[55]	_	_
8-13	963-975	aromatherapy	abstract[53]|substance[54]|abstract[55]|substance	new[53]|new[54]|new[55]|new	_	_
8-14	976-979	and	abstract[53]|substance[54]|abstract[55]	new[53]|new[54]|new[55]	_	_
8-15	980-989	Ayurvedic	abstract[53]|substance[54]|abstract[55]|abstract[57]	new[53]|new[54]|new[55]|new[57]	coref	15-15[90_57]
8-16	990-998	medicine	abstract[53]|substance[54]|abstract[55]|abstract[57]	new[53]|new[54]|new[55]|new[57]	_	_
8-17	999-1001	is	_	_	_	_
8-18	1002-1006	well	_	_	_	_
8-19	1007-1017	documented	_	_	_	_
8-20	1018-1019	.	_	_	_	_

#Text=There is currently little evidence their use confers actual medical benefits , yet their use remains widespread due to their aesthetic , historical , and cultural significance .
9-1	1020-1025	There	_	_	_	_
9-2	1026-1028	is	_	_	_	_
9-3	1029-1038	currently	abstract[58]	new[58]	_	_
9-4	1039-1045	little	abstract[58]	new[58]	_	_
9-5	1046-1054	evidence	abstract[58]	new[58]	_	_
9-6	1055-1060	their	substance|abstract[60]	giv|giv[60]	ana|coref|ana|coref	9-14|9-14[63_60]|9-14|9-14[63_60]
9-7	1061-1064	use	abstract[60]	giv[60]	_	_
9-8	1065-1072	confers	_	_	_	_
9-9	1073-1079	actual	abstract[61]	new[61]	_	_
9-10	1080-1087	medical	abstract[61]	new[61]	_	_
9-11	1088-1096	benefits	abstract[61]	new[61]	_	_
9-12	1097-1098	,	_	_	_	_
9-13	1099-1102	yet	_	_	_	_
9-14	1103-1108	their	substance|abstract[63]	giv|giv[63]	ana|ana	9-20|9-20
9-15	1109-1112	use	abstract[63]	giv[63]	_	_
9-16	1113-1120	remains	_	_	_	_
9-17	1121-1131	widespread	_	_	_	_
9-18	1132-1135	due	_	_	_	_
9-19	1136-1138	to	_	_	_	_
9-20	1139-1144	their	substance|abstract[65]	giv|new[65]	_	_
9-21	1145-1154	aesthetic	abstract[65]	new[65]	_	_
9-22	1155-1156	,	abstract[65]	new[65]	_	_
9-23	1157-1167	historical	abstract[65]	new[65]	_	_
9-24	1168-1169	,	abstract[65]	new[65]	_	_
9-25	1170-1173	and	abstract[65]	new[65]	_	_
9-26	1174-1182	cultural	abstract[65]	new[65]	_	_
9-27	1183-1195	significance	abstract[65]	new[65]	_	_
9-28	1196-1197	.	_	_	_	_

#Text=On the other hand , a number of highly functionalized , non-volatile sesquiterpenes of plant origin have demonstrated highly specific biological activity and have therefore been investigated for their clinical potential .
10-1	1198-1200	On	_	_	_	_
10-2	1201-1204	the	_	_	_	_
10-3	1205-1210	other	_	_	_	_
10-4	1211-1215	hand	_	_	_	_
10-5	1216-1217	,	_	_	_	_
10-6	1218-1219	a	substance[66]	giv[66]	ana	10-29[0_66]
10-7	1220-1226	number	substance[66]	giv[66]	_	_
10-8	1227-1229	of	substance[66]	giv[66]	_	_
10-9	1230-1236	highly	substance[66]	giv[66]	_	_
10-10	1237-1251	functionalized	substance[66]	giv[66]	_	_
10-11	1252-1253	,	substance[66]	giv[66]	_	_
10-12	1254-1266	non-volatile	substance[66]	giv[66]	_	_
10-13	1267-1281	sesquiterpenes	substance[66]	giv[66]	_	_
10-14	1282-1284	of	substance[66]	giv[66]	_	_
10-15	1285-1290	plant	substance[66]|plant|abstract[68]	giv[66]|new|new[68]	coref|coref	11-7|11-7
10-16	1291-1297	origin	substance[66]|abstract[68]	giv[66]|new[68]	_	_
10-17	1298-1302	have	_	_	_	_
10-18	1303-1315	demonstrated	_	_	_	_
10-19	1316-1322	highly	abstract[69]	new[69]	_	_
10-20	1323-1331	specific	abstract[69]	new[69]	_	_
10-21	1332-1342	biological	abstract[69]	new[69]	_	_
10-22	1343-1351	activity	abstract[69]	new[69]	_	_
10-23	1352-1355	and	_	_	_	_
10-24	1356-1360	have	_	_	_	_
10-25	1361-1370	therefore	_	_	_	_
10-26	1371-1375	been	_	_	_	_
10-27	1376-1388	investigated	_	_	_	_
10-28	1389-1392	for	_	_	_	_
10-29	1393-1398	their	substance|abstract[71]	giv|new[71]	_	_
10-30	1399-1407	clinical	abstract[71]	new[71]	_	_
10-31	1408-1417	potential	abstract[71]	new[71]	_	_
10-32	1418-1419	.	_	_	_	_

#Text=A selection of these medically useful plant sesquiterpenoids follows .
11-1	1420-1421	A	abstract[72]	new[72]	_	_
11-2	1422-1431	selection	abstract[72]	new[72]	_	_
11-3	1432-1434	of	abstract[72]	new[72]	_	_
11-4	1435-1440	these	abstract[72]|substance[74]	new[72]|new[74]	_	_
11-5	1441-1450	medically	abstract[72]|substance[74]	new[72]|new[74]	_	_
11-6	1451-1457	useful	abstract[72]|substance[74]	new[72]|new[74]	_	_
11-7	1458-1463	plant	abstract[72]|plant|substance[74]	new[72]|giv|new[74]	coref	29-7
11-8	1464-1480	sesquiterpenoids	abstract[72]|substance[74]	new[72]|new[74]	_	_
11-9	1481-1488	follows	_	_	_	_
11-10	1489-1490	.	_	_	_	_

#Text=4.1 .
12-1	1491-1494	4.1	abstract	new	_	_
12-2	1495-1496	.	_	_	_	_

#Text=Artemisinin
13-1	1497-1508	Artemisinin	person	new	coref	14-21[83_0]

#Text=Wormwood ( Artemisia annua L. , or qinghaosu , Asteraceae ) is native to China and is the source of the sesquiterpene endoperoxide artemisinin , shown to be highly effective at treating malaria .
14-1	1509-1517	Wormwood	person	new	_	_
14-2	1518-1519	(	_	_	_	_
14-3	1520-1529	Artemisia	_	_	_	_
14-4	1530-1535	annua	_	_	_	_
14-5	1536-1538	L.	_	_	_	_
14-6	1539-1540	,	_	_	_	_
14-7	1541-1543	or	_	_	_	_
14-8	1544-1553	qinghaosu	plant	new	appos	14-10
14-9	1554-1555	,	_	_	_	_
14-10	1556-1566	Asteraceae	plant	giv	coref	15-24[93_0]
14-11	1567-1568	)	_	_	_	_
14-12	1569-1571	is	_	_	_	_
14-13	1572-1578	native	_	_	_	_
14-14	1579-1581	to	_	_	_	_
14-15	1582-1587	China	place	new	_	_
14-16	1588-1591	and	_	_	_	_
14-17	1592-1594	is	_	_	_	_
14-18	1595-1598	the	abstract[81]	new[81]	_	_
14-19	1599-1605	source	abstract[81]	new[81]	_	_
14-20	1606-1608	of	abstract[81]	new[81]	_	_
14-21	1609-1612	the	abstract[81]|person[83]	new[81]|giv[83]	coref	17-1[0_83]
14-22	1613-1626	sesquiterpene	abstract[81]|person[83]	new[81]|giv[83]	_	_
14-23	1627-1639	endoperoxide	abstract[81]|substance|person[83]	new[81]|new|giv[83]	coref	17-9
14-24	1640-1651	artemisinin	abstract[81]|person[83]	new[81]|giv[83]	_	_
14-25	1652-1653	,	_	_	_	_
14-26	1654-1659	shown	_	_	_	_
14-27	1660-1662	to	_	_	_	_
14-28	1663-1665	be	_	_	_	_
14-29	1666-1672	highly	_	_	_	_
14-30	1673-1682	effective	_	_	_	_
14-31	1683-1685	at	_	_	_	_
14-32	1686-1694	treating	_	_	_	_
14-33	1695-1702	malaria	abstract	new	coref	15-39
14-34	1703-1704	.	_	_	_	_

#Text=In the early 1970s , phytochemists such as Youyou Tu investigated plants used in traditional Chinese herbal medicine and identified the usefulness of the traditional remedy qinghaosu in eradicating Plasmodium spp . infections , the causative agent of malaria , for which she received a Nobel Prize in Medicine in 2015 .
15-1	1705-1707	In	_	_	_	_
15-2	1708-1711	the	time[85]	new[85]	_	_
15-3	1712-1717	early	time[85]	new[85]	_	_
15-4	1718-1723	1970s	time[85]	new[85]	_	_
15-5	1724-1725	,	_	_	_	_
15-6	1726-1739	phytochemists	person[86]	new[86]	_	_
15-7	1740-1744	such	person[86]	new[86]	_	_
15-8	1745-1747	as	person[86]	new[86]	_	_
15-9	1748-1754	Youyou	person[86]|person[87]	new[86]|new[87]	_	_
15-10	1755-1757	Tu	person[86]|person[87]	new[86]|new[87]	_	_
15-11	1758-1770	investigated	_	_	_	_
15-12	1771-1777	plants	plant	new	coref	25-20
15-13	1778-1782	used	_	_	_	_
15-14	1783-1785	in	_	_	_	_
15-15	1786-1797	traditional	abstract[90]	giv[90]	coref	15-49[0_90]
15-16	1798-1805	Chinese	abstract[90]	giv[90]	_	_
15-17	1806-1812	herbal	abstract|abstract[90]	new|giv[90]	_	_
15-18	1813-1821	medicine	abstract[90]	giv[90]	_	_
15-19	1822-1825	and	_	_	_	_
15-20	1826-1836	identified	_	_	_	_
15-21	1837-1840	the	abstract[91]	new[91]	_	_
15-22	1841-1851	usefulness	abstract[91]	new[91]	_	_
15-23	1852-1854	of	abstract[91]	new[91]	_	_
15-24	1855-1858	the	abstract[91]|plant[93]	new[91]|giv[93]	_	_
15-25	1859-1870	traditional	abstract[91]|plant[93]	new[91]|giv[93]	_	_
15-26	1871-1877	remedy	abstract[91]|substance|plant[93]	new[91]|new|giv[93]	_	_
15-27	1878-1887	qinghaosu	abstract[91]|plant[93]	new[91]|giv[93]	_	_
15-28	1888-1890	in	_	_	_	_
15-29	1891-1902	eradicating	_	_	_	_
15-30	1903-1913	Plasmodium	substance	new	coref	22-13
15-31	1914-1917	spp	_	_	_	_
15-32	1918-1919	.	_	_	_	_
15-33	1920-1930	infections	abstract	new	_	_
15-34	1931-1932	,	_	_	_	_
15-35	1933-1936	the	person[96]	new[96]	ana	15-43[0_96]
15-36	1937-1946	causative	person[96]	new[96]	_	_
15-37	1947-1952	agent	person[96]	new[96]	_	_
15-38	1953-1955	of	person[96]	new[96]	_	_
15-39	1956-1963	malaria	person[96]|abstract	new[96]|giv	_	_
15-40	1964-1965	,	_	_	_	_
15-41	1966-1969	for	_	_	_	_
15-42	1970-1975	which	_	_	_	_
15-43	1976-1979	she	person	giv	_	_
15-44	1980-1988	received	_	_	_	_
15-45	1989-1990	a	abstract[99]	new[99]	_	_
15-46	1991-1996	Nobel	abstract[99]	new[99]	_	_
15-47	1997-2002	Prize	abstract[99]	new[99]	_	_
15-48	2003-2005	in	_	_	_	_
15-49	2006-2014	Medicine	abstract	giv	ana	16-1
15-50	2015-2017	in	_	_	_	_
15-51	2018-2022	2015	time	new	_	_
15-52	2023-2024	.	_	_	_	_

#Text=It is more effective against a broader range of life cycle stages of the apicomplexan parasite than traditional anti-malarials such as quinine .
16-1	2025-2027	It	abstract	giv	_	_
16-2	2028-2030	is	_	_	_	_
16-3	2031-2035	more	_	_	_	_
16-4	2036-2045	effective	_	_	_	_
16-5	2046-2053	against	_	_	_	_
16-6	2054-2055	a	abstract[103]	new[103]	_	_
16-7	2056-2063	broader	abstract[103]	new[103]	_	_
16-8	2064-2069	range	abstract[103]	new[103]	_	_
16-9	2070-2072	of	abstract[103]	new[103]	_	_
16-10	2073-2077	life	abstract[103]|abstract|abstract[106]	new[103]|new|new[106]	coref|coref	24-28[150_106]|24-28[150_106]
16-11	2078-2083	cycle	abstract[103]|abstract|abstract[106]	new[103]|new|new[106]	_	_
16-12	2084-2090	stages	abstract[103]|abstract[106]	new[103]|new[106]	_	_
16-13	2091-2093	of	abstract[103]|abstract[106]	new[103]|new[106]	_	_
16-14	2094-2097	the	abstract[103]|abstract[106]|person[107]	new[103]|new[106]|new[107]	coref	23-7[136_0]
16-15	2098-2110	apicomplexan	abstract[103]|abstract[106]|person[107]	new[103]|new[106]|new[107]	_	_
16-16	2111-2119	parasite	abstract[103]|abstract[106]|person[107]	new[103]|new[106]|new[107]	_	_
16-17	2120-2124	than	abstract[103]|abstract[106]|person[107]	new[103]|new[106]|new[107]	_	_
16-18	2125-2136	traditional	abstract[103]|abstract[106]|person[107]|substance[108]	new[103]|new[106]|new[107]|new[108]	_	_
16-19	2137-2151	anti-malarials	abstract[103]|abstract[106]|person[107]|substance[108]	new[103]|new[106]|new[107]|new[108]	_	_
16-20	2152-2156	such	abstract[103]|abstract[106]|person[107]|substance[108]	new[103]|new[106]|new[107]|new[108]	_	_
16-21	2157-2159	as	abstract[103]|abstract[106]|person[107]|substance[108]	new[103]|new[106]|new[107]|new[108]	_	_
16-22	2160-2167	quinine	abstract[103]|abstract[106]|person[107]|substance[108]|substance	new[103]|new[106]|new[107]|new[108]|new	_	_
16-23	2168-2169	.	_	_	_	_

#Text=Artemisinin is a sesquiterpene lactone with an unusual endoperoxide ring which imparts its anti-malarial properties (
17-1	2170-2181	Artemisinin	substance	giv	coref	17-3[111_0]
17-2	2182-2184	is	_	_	_	_
17-3	2185-2186	a	substance[111]	giv[111]	ana	17-13[0_111]
17-4	2187-2200	sesquiterpene	substance[111]	giv[111]	_	_
17-5	2201-2208	lactone	substance[111]	giv[111]	_	_
17-6	2209-2213	with	substance[111]	giv[111]	_	_
17-7	2214-2216	an	substance[111]|object[113]	giv[111]|new[113]	coref	32-13[203_113]
17-8	2217-2224	unusual	substance[111]|object[113]	giv[111]|new[113]	_	_
17-9	2225-2237	endoperoxide	substance[111]|substance|object[113]	giv[111]|giv|new[113]	coref	21-7
17-10	2238-2242	ring	substance[111]|object[113]	giv[111]|new[113]	_	_
17-11	2243-2248	which	_	_	_	_
17-12	2249-2256	imparts	_	_	_	_
17-13	2257-2260	its	substance|abstract[115]	giv|new[115]	coref|coref	22-11|22-11
17-14	2261-2274	anti-malarial	abstract[115]	new[115]	_	_
17-15	2275-2285	properties	abstract[115]	new[115]	_	_
17-16	2286-2287	(	_	_	_	_

#Text=Figure 6
18-1	2288-2294	Figure	object[116]	new[116]	coref	27-1[163_116]
18-2	2295-2296	6	object[116]	new[116]	_	_

#Text=) .
19-1	2297-2298	)	_	_	_	_
19-2	2299-2300	.	_	_	_	_

#Text=The mechanism of action is still unclear , and several possibilities have been proposed .
20-1	2301-2304	The	abstract[117]	new[117]	_	_
20-2	2305-2314	mechanism	abstract[117]	new[117]	_	_
20-3	2315-2317	of	abstract[117]	new[117]	_	_
20-4	2318-2324	action	abstract[117]|abstract	new[117]|new	_	_
20-5	2325-2327	is	_	_	_	_
20-6	2328-2333	still	_	_	_	_
20-7	2334-2341	unclear	_	_	_	_
20-8	2342-2343	,	_	_	_	_
20-9	2344-2347	and	_	_	_	_
20-10	2348-2355	several	abstract[119]	new[119]	_	_
20-11	2356-2369	possibilities	abstract[119]	new[119]	_	_
20-12	2370-2374	have	_	_	_	_
20-13	2375-2379	been	_	_	_	_
20-14	2380-2388	proposed	_	_	_	_
20-15	2389-2390	.	_	_	_	_

#Text=Most involve the degradation of the endoperoxide bridge in a heme-dependent process to form carbon centered radicals which then alkylate multiple targets including heme and proteins .
21-1	2391-2395	Most	_	_	_	_
21-2	2396-2403	involve	abstract|abstract	new|new	coref|none|none|none|coref|none|none|none	22-1[129_0]|21-2[0_129]|21-2[0_206]|23-13|22-1[129_0]|21-2[0_129]|21-2[0_206]|23-13
21-3	2404-2407	the	abstract[120]	new[120]	_	_
21-4	2408-2419	degradation	abstract[120]	new[120]	_	_
21-5	2420-2422	of	abstract[120]	new[120]	_	_
21-6	2423-2426	the	abstract[120]|object[122]	new[120]|new[122]	_	_
21-7	2427-2439	endoperoxide	abstract[120]|substance|object[122]	new[120]|giv|new[122]	coref	32-14
21-8	2440-2446	bridge	abstract[120]|object[122]	new[120]|new[122]	_	_
21-9	2447-2449	in	_	_	_	_
21-10	2450-2451	a	event[123]	new[123]	coref	33-6[205_123]
21-11	2452-2466	heme-dependent	event[123]	new[123]	_	_
21-12	2467-2474	process	event[123]	new[123]	_	_
21-13	2475-2477	to	_	_	_	_
21-14	2478-2482	form	event	new	coref	32-9[201_0]
21-15	2483-2489	carbon	substance	giv	_	_
21-16	2490-2498	centered	_	_	_	_
21-17	2499-2507	radicals	substance	new	_	_
21-18	2508-2513	which	_	_	_	_
21-19	2514-2518	then	_	_	_	_
21-20	2519-2527	alkylate	abstract[126]	new[126]	_	_
21-21	2528-2536	multiple	abstract[126]	new[126]	_	_
21-22	2537-2544	targets	abstract[126]	new[126]	_	_
21-23	2545-2554	including	abstract[126]	new[126]	_	_
21-24	2555-2559	heme	abstract[126]|substance	new[126]|new	coref	22-4
21-25	2560-2563	and	abstract[126]	new[126]	_	_
21-26	2564-2572	proteins	abstract[126]|substance	new[126]|new	_	_
21-27	2573-2574	.	_	_	_	_

#Text=The involvement of heme is consistent with the specificity of artemisinin towards Plasmodium spp . .
22-1	2575-2578	The	abstract[129]	new[129]	_	_
22-2	2579-2590	involvement	abstract[129]	new[129]	_	_
22-3	2591-2593	of	abstract[129]	new[129]	_	_
22-4	2594-2598	heme	abstract[129]|substance	new[129]|giv	coref	23-19[139_0]
22-5	2599-2601	is	_	_	_	_
22-6	2602-2612	consistent	_	_	_	_
22-7	2613-2617	with	_	_	_	_
22-8	2618-2621	the	abstract[131]	new[131]	_	_
22-9	2622-2633	specificity	abstract[131]	new[131]	_	_
22-10	2634-2636	of	abstract[131]	new[131]	_	_
22-11	2637-2648	artemisinin	abstract[131]|person	new[131]|giv	coref	24-5
22-12	2649-2656	towards	abstract[131]	new[131]	_	_
22-13	2657-2667	Plasmodium	abstract[131]|substance	new[131]|giv	_	_
22-14	2668-2671	spp	abstract[131]	new[131]	_	_
22-15	2672-2673	.	_	_	_	_
22-16	2674-2675	.	_	_	_	_

#Text=The direct cause of toxicity to the parasite is unclear but may involve interference with the conversion of heme to hemozoin , although this hypothesis has been disputed ( and reviewed in reference ) .
23-1	2676-2679	The	abstract[134]	new[134]	_	_
23-2	2680-2686	direct	abstract[134]	new[134]	_	_
23-3	2687-2692	cause	abstract[134]	new[134]	_	_
23-4	2693-2695	of	abstract[134]	new[134]	_	_
23-5	2696-2704	toxicity	abstract[134]|abstract[135]	new[134]|new[135]	_	_
23-6	2705-2707	to	abstract[134]|abstract[135]	new[134]|new[135]	_	_
23-7	2708-2711	the	abstract[134]|abstract[135]|person[136]	new[134]|new[135]|giv[136]	_	_
23-8	2712-2720	parasite	abstract[134]|abstract[135]|person[136]	new[134]|new[135]|giv[136]	_	_
23-9	2721-2723	is	_	_	_	_
23-10	2724-2731	unclear	_	_	_	_
23-11	2732-2735	but	_	_	_	_
23-12	2736-2739	may	_	_	_	_
23-13	2740-2747	involve	abstract	new	none	32-8
23-14	2748-2760	interference	abstract[137]	new[137]	_	_
23-15	2761-2765	with	abstract[137]	new[137]	_	_
23-16	2766-2769	the	abstract[137]|abstract[138]	new[137]|new[138]	_	_
23-17	2770-2780	conversion	abstract[137]|abstract[138]	new[137]|new[138]	_	_
23-18	2781-2783	of	abstract[137]|abstract[138]	new[137]|new[138]	_	_
23-19	2784-2788	heme	abstract[137]|abstract[138]|substance[139]	new[137]|new[138]|giv[139]	_	_
23-20	2789-2791	to	abstract[137]|abstract[138]|substance[139]	new[137]|new[138]|giv[139]	_	_
23-21	2792-2800	hemozoin	abstract[137]|abstract[138]|substance[139]|substance	new[137]|new[138]|giv[139]|new	_	_
23-22	2801-2802	,	_	_	_	_
23-23	2803-2811	although	_	_	_	_
23-24	2812-2816	this	abstract[141]	new[141]	_	_
23-25	2817-2827	hypothesis	abstract[141]	new[141]	_	_
23-26	2828-2831	has	_	_	_	_
23-27	2832-2836	been	_	_	_	_
23-28	2837-2845	disputed	_	_	_	_
23-29	2846-2847	(	_	_	_	_
23-30	2848-2851	and	_	_	_	_
23-31	2852-2860	reviewed	_	_	_	_
23-32	2861-2863	in	_	_	_	_
23-33	2864-2873	reference	abstract	new	_	_
23-34	2874-2875	)	_	_	_	_
23-35	2876-2877	.	_	_	_	_

#Text=The early stages of artemisinin biosynthesis in glandular trichomes of A. annua are now understood at the biochemical and molecular levels , although the exact mechanism of the later stages remains unclear .
24-1	2878-2881	The	abstract[143]	new[143]	_	_
24-2	2882-2887	early	abstract[143]	new[143]	_	_
24-3	2888-2894	stages	abstract[143]	new[143]	_	_
24-4	2895-2897	of	abstract[143]	new[143]	_	_
24-5	2898-2909	artemisinin	abstract[143]|person|abstract[145]	new[143]|giv|new[145]	coref|coref	25-16|25-16
24-6	2910-2922	biosynthesis	abstract[143]|abstract[145]	new[143]|new[145]	_	_
24-7	2923-2925	in	abstract[143]|abstract[145]	new[143]|new[145]	_	_
24-8	2926-2935	glandular	abstract[143]|abstract[145]|plant[146]	new[143]|new[145]|new[146]	_	_
24-9	2936-2945	trichomes	abstract[143]|abstract[145]|plant[146]	new[143]|new[145]|new[146]	_	_
24-10	2946-2948	of	abstract[143]|abstract[145]|plant[146]	new[143]|new[145]|new[146]	_	_
24-11	2949-2951	A.	abstract[143]|abstract[145]|plant[146]|person	new[143]|new[145]|new[146]|new	_	_
24-12	2952-2957	annua	abstract[143]|abstract[145]|plant[146]	new[143]|new[145]|new[146]	_	_
24-13	2958-2961	are	_	_	_	_
24-14	2962-2965	now	_	_	_	_
24-15	2966-2976	understood	_	_	_	_
24-16	2977-2979	at	_	_	_	_
24-17	2980-2983	the	abstract[148]	new[148]	_	_
24-18	2984-2995	biochemical	abstract[148]	new[148]	_	_
24-19	2996-2999	and	abstract[148]	new[148]	_	_
24-20	3000-3009	molecular	abstract[148]	new[148]	_	_
24-21	3010-3016	levels	abstract[148]	new[148]	_	_
24-22	3017-3018	,	_	_	_	_
24-23	3019-3027	although	_	_	_	_
24-24	3028-3031	the	abstract[149]	new[149]	_	_
24-25	3032-3037	exact	abstract[149]	new[149]	_	_
24-26	3038-3047	mechanism	abstract[149]	new[149]	_	_
24-27	3048-3050	of	abstract[149]	new[149]	_	_
24-28	3051-3054	the	abstract[149]|abstract[150]	new[149]|giv[150]	_	_
24-29	3055-3060	later	abstract[149]|abstract[150]	new[149]|giv[150]	_	_
24-30	3061-3067	stages	abstract[149]|abstract[150]	new[149]|giv[150]	_	_
24-31	3068-3075	remains	_	_	_	_
24-32	3076-3083	unclear	_	_	_	_
24-33	3084-3085	.	_	_	_	_

#Text=Current efforts now focus on the regulation of this pathway in an effort to improve artemisinin production directly in plants .
25-1	3086-3093	Current	abstract[151]	new[151]	_	_
25-2	3094-3101	efforts	abstract[151]	new[151]	_	_
25-3	3102-3105	now	_	_	_	_
25-4	3106-3111	focus	_	_	_	_
25-5	3112-3114	on	_	_	_	_
25-6	3115-3118	the	abstract[152]	new[152]	_	_
25-7	3119-3129	regulation	abstract[152]	new[152]	_	_
25-8	3130-3132	of	abstract[152]	new[152]	_	_
25-9	3133-3137	this	abstract[152]|abstract[153]	new[152]|new[153]	coref	26-1[158_153]
25-10	3138-3145	pathway	abstract[152]|abstract[153]	new[152]|new[153]	_	_
25-11	3146-3148	in	_	_	_	_
25-12	3149-3151	an	abstract[154]	new[154]	_	_
25-13	3152-3158	effort	abstract[154]	new[154]	_	_
25-14	3159-3161	to	_	_	_	_
25-15	3162-3169	improve	_	_	_	_
25-16	3170-3181	artemisinin	person|abstract[156]	giv|new[156]	_	_
25-17	3182-3192	production	abstract[156]	new[156]	_	_
25-18	3193-3201	directly	_	_	_	_
25-19	3202-3204	in	_	_	_	_
25-20	3205-3211	plants	plant	giv	_	_
25-21	3212-3213	.	_	_	_	_

#Text=The pathway begins with the conversion of FDP to amorpha-4,11-diene by amorpha-4,11-diene synthase (
26-1	3214-3217	The	abstract[158]	giv[158]	_	_
26-2	3218-3225	pathway	abstract[158]	giv[158]	_	_
26-3	3226-3232	begins	_	_	_	_
26-4	3233-3237	with	_	_	_	_
26-5	3238-3241	the	event[159]	new[159]	_	_
26-6	3242-3252	conversion	event[159]	new[159]	_	_
26-7	3253-3255	of	event[159]	new[159]	_	_
26-8	3256-3259	FDP	event[159]|substance	new[159]|giv	_	_
26-9	3260-3262	to	_	_	_	_
26-10	3263-3281	amorpha-4,11-diene	substance	new	coref	30-11[181_0]
26-11	3282-3284	by	_	_	_	_
26-12	3285-3303	amorpha-4,11-diene	abstract[162]	new[162]	_	_
26-13	3304-3312	synthase	abstract[162]	new[162]	_	_
26-14	3313-3314	(	_	_	_	_

#Text=Figure 6
27-1	3315-3321	Figure	object[163]	giv[163]	_	_
27-2	3322-3323	6	object[163]	giv[163]	_	_

#Text=) .
28-1	3324-3325	)	_	_	_	_
28-2	3326-3327	.	_	_	_	_

#Text=Biochemical characterization and metabolite profiling of plant tissue indicated the presence of this olefin as well as its oxygenated derivatives artemisinic alcohol and aldehyde , dihydroartemisinic alcohol and aldehyde , and dihydroartemisinic acid .
29-1	3328-3339	Biochemical	substance|abstract[165]	new|new[165]	_	_
29-2	3340-3356	characterization	abstract[165]	new[165]	_	_
29-3	3357-3360	and	_	_	_	_
29-4	3361-3371	metabolite	object[166]	new[166]	_	_
29-5	3372-3381	profiling	object[166]	new[166]	_	_
29-6	3382-3384	of	object[166]	new[166]	_	_
29-7	3385-3390	plant	object[166]|plant|object[168]	new[166]|giv|new[168]	_	_
29-8	3391-3397	tissue	object[166]|object[168]	new[166]|new[168]	_	_
29-9	3398-3407	indicated	_	_	_	_
29-10	3408-3411	the	abstract[169]	new[169]	_	_
29-11	3412-3420	presence	abstract[169]	new[169]	_	_
29-12	3421-3423	of	abstract[169]	new[169]	_	_
29-13	3424-3428	this	abstract[169]|substance[170]	new[169]|new[170]	ana	29-18[0_170]
29-14	3429-3435	olefin	abstract[169]|substance[170]	new[169]|new[170]	_	_
29-15	3436-3438	as	_	_	_	_
29-16	3439-3443	well	_	_	_	_
29-17	3444-3446	as	_	_	_	_
29-18	3447-3450	its	substance|substance[172]	giv|new[172]	_	_
29-19	3451-3461	oxygenated	substance[172]	new[172]	_	_
29-20	3462-3473	derivatives	substance[172]	new[172]	_	_
29-21	3474-3485	artemisinic	substance[173]	new[173]	_	_
29-22	3486-3493	alcohol	substance[173]	new[173]	_	_
29-23	3494-3497	and	_	_	_	_
29-24	3498-3506	aldehyde	substance	new	_	_
29-25	3507-3508	,	_	_	_	_
29-26	3509-3527	dihydroartemisinic	substance[175]	new[175]	coref	30-13[183_175]
29-27	3528-3535	alcohol	substance[175]	new[175]	_	_
29-28	3536-3539	and	_	_	_	_
29-29	3540-3548	aldehyde	substance	new	coref	30-16
29-30	3549-3550	,	_	_	_	_
29-31	3551-3554	and	_	_	_	_
29-32	3555-3573	dihydroartemisinic	substance[177]	new[177]	coref	31-7[194_177]
29-33	3574-3578	acid	substance[177]	new[177]	_	_
29-34	3579-3580	.	_	_	_	_

#Text=Following the cloning and expression of CYP71AV1 , which converts amorpha-4,11-diene to artemisinic alcohol and aldehyde , Zhang et al. characterized the artemisinic aldehyde Δ11(13 ) reductase ( Double bond reductase 2 , Dbr2 ) , which preferentially reduces artemisinic aldehyde to dihydroartemisinic aldehyde .
30-1	3581-3590	Following	_	_	_	_
30-2	3591-3594	the	abstract[178]	new[178]	_	_
30-3	3595-3602	cloning	abstract[178]	new[178]	_	_
30-4	3603-3606	and	_	_	_	_
30-5	3607-3617	expression	abstract[179]	new[179]	_	_
30-6	3618-3620	of	abstract[179]	new[179]	_	_
30-7	3621-3629	CYP71AV1	abstract[179]|abstract	new[179]|new	_	_
30-8	3630-3631	,	_	_	_	_
30-9	3632-3637	which	_	_	_	_
30-10	3638-3646	converts	_	_	_	_
30-11	3647-3665	amorpha-4,11-diene	substance[181]	giv[181]	_	_
30-12	3666-3668	to	substance[181]	giv[181]	_	_
30-13	3669-3680	artemisinic	substance[181]|substance|substance[183]	giv[181]|new|giv[183]	coref|coref	30-23|30-23
30-14	3681-3688	alcohol	substance[181]|substance[183]	giv[181]|giv[183]	_	_
30-15	3689-3692	and	substance[181]	giv[181]	_	_
30-16	3693-3701	aldehyde	substance[181]|substance	giv[181]|giv	coref	30-22[187_0]
30-17	3702-3703	,	substance[181]	giv[181]	_	_
30-18	3704-3709	Zhang	substance[181]|person	giv[181]|new	_	_
30-19	3710-3712	et	substance[181]	giv[181]	_	_
30-20	3713-3716	al.	substance[181]	giv[181]	_	_
30-21	3717-3730	characterized	_	_	_	_
30-22	3731-3734	the	substance[187]	giv[187]	coref	30-40[191_187]
30-23	3735-3746	artemisinic	place|substance[187]	giv|giv[187]	_	_
30-24	3747-3755	aldehyde	substance[187]	giv[187]	_	_
30-25	3756-3762	Δ11(13	substance[187]	giv[187]	_	_
30-26	3763-3764	)	_	_	_	_
30-27	3765-3774	reductase	abstract	new	appos	30-29[190_0]
30-28	3775-3776	(	_	_	_	_
30-29	3777-3783	Double	abstract[190]	giv[190]	_	_
30-30	3784-3788	bond	abstract|abstract[190]	new|giv[190]	_	_
30-31	3789-3798	reductase	abstract[190]	giv[190]	_	_
30-32	3799-3800	2	abstract[190]	giv[190]	_	_
30-33	3801-3802	,	abstract[190]	giv[190]	_	_
30-34	3803-3807	Dbr2	abstract[190]	giv[190]	_	_
30-35	3808-3809	)	_	_	_	_
30-36	3810-3811	,	_	_	_	_
30-37	3812-3817	which	_	_	_	_
30-38	3818-3832	preferentially	_	_	_	_
30-39	3833-3840	reduces	_	_	_	_
30-40	3841-3852	artemisinic	substance[191]	giv[191]	coref	30-43[192_191]
30-41	3853-3861	aldehyde	substance[191]	giv[191]	_	_
30-42	3862-3864	to	_	_	_	_
30-43	3865-3883	dihydroartemisinic	substance[192]	giv[192]	coref	31-10[0_192]
30-44	3884-3892	aldehyde	substance[192]	giv[192]	_	_
30-45	3893-3894	.	_	_	_	_

#Text=This substrate is then converted to dihydroartemisinic acid by aldehyde dehydrogenase 1 ( Aldh1 ) .
31-1	3895-3899	This	object[193]	new[193]	_	_
31-2	3900-3909	substrate	object[193]	new[193]	_	_
31-3	3910-3912	is	_	_	_	_
31-4	3913-3917	then	_	_	_	_
31-5	3918-3927	converted	_	_	_	_
31-6	3928-3930	to	_	_	_	_
31-7	3931-3949	dihydroartemisinic	substance[194]	giv[194]	coref	32-2[199_194]
31-8	3950-3954	acid	substance[194]	giv[194]	_	_
31-9	3955-3957	by	_	_	_	_
31-10	3958-3966	aldehyde	substance|time[197]	giv|new[197]	_	_
31-11	3967-3980	dehydrogenase	time|time[197]	new|new[197]	_	_
31-12	3981-3982	1	time[197]	new[197]	_	_
31-13	3983-3984	(	time[197]	new[197]	_	_
31-14	3985-3990	Aldh1	time[197]|time	new[197]|new	_	_
31-15	3991-3992	)	time[197]	new[197]	_	_
31-16	3993-3994	.	_	_	_	_

#Text=From dihydroartemisinic acid , the remaining steps involve the photooxidative formation of the endoperoxide ring .
32-1	3995-3999	From	_	_	_	_
32-2	4000-4018	dihydroartemisinic	substance[199]	giv[199]	_	_
32-3	4019-4023	acid	substance[199]	giv[199]	_	_
32-4	4024-4025	,	_	_	_	_
32-5	4026-4029	the	event[200]	new[200]	_	_
32-6	4030-4039	remaining	event[200]	new[200]	_	_
32-7	4040-4045	steps	event[200]	new[200]	_	_
32-8	4046-4053	involve	abstract	new	coref	33-11[206_0]
32-9	4054-4057	the	event[201]	new[201]	_	_
32-10	4058-4072	photooxidative	event[201]	new[201]	_	_
32-11	4073-4082	formation	event[201]	new[201]	_	_
32-12	4083-4085	of	event[201]	new[201]	_	_
32-13	4086-4089	the	event[201]|object[203]	new[201]|giv[203]	_	_
32-14	4090-4102	endoperoxide	event[201]|substance|object[203]	new[201]|giv|giv[203]	_	_
32-15	4103-4107	ring	event[201]|object[203]	new[201]|giv[203]	_	_
32-16	4108-4109	.	_	_	_	_

#Text=However , the details of this process , such as the potential involvement of additional enzyme activities , are currently unclear .
33-1	4110-4117	However	_	_	_	_
33-2	4118-4119	,	_	_	_	_
33-3	4120-4123	the	abstract[204]	new[204]	_	_
33-4	4124-4131	details	abstract[204]	new[204]	_	_
33-5	4132-4134	of	abstract[204]	new[204]	_	_
33-6	4135-4139	this	abstract[204]|event[205]	new[204]|giv[205]	_	_
33-7	4140-4147	process	abstract[204]|event[205]	new[204]|giv[205]	_	_
33-8	4148-4149	,	abstract[204]	new[204]	_	_
33-9	4150-4154	such	abstract[204]	new[204]	_	_
33-10	4155-4157	as	abstract[204]	new[204]	_	_
33-11	4158-4161	the	abstract[204]|abstract[206]	new[204]|new[206]	_	_
33-12	4162-4171	potential	abstract[204]|abstract[206]	new[204]|new[206]	_	_
33-13	4172-4183	involvement	abstract[204]|abstract[206]	new[204]|new[206]	_	_
33-14	4184-4186	of	abstract[204]|abstract[206]	new[204]|new[206]	_	_
33-15	4187-4197	additional	abstract[204]|abstract[206]|abstract[208]	new[204]|new[206]|new[208]	_	_
33-16	4198-4204	enzyme	abstract[204]|abstract[206]|substance|abstract[208]	new[204]|new[206]|new|new[208]	_	_
33-17	4205-4215	activities	abstract[204]|abstract[206]|abstract[208]	new[204]|new[206]|new[208]	_	_
33-18	4216-4217	,	_	_	_	_
33-19	4218-4221	are	_	_	_	_
33-20	4222-4231	currently	_	_	_	_
33-21	4232-4239	unclear	_	_	_	_
33-22	4240-4241	.	_	_	_	_
